HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Enhanced expression and secretion of antimicrobial peptides in atopic dermatitis and after superficial skin injury.

Abstract
Human skin can defend itself against potentially invading microorganisms by production of antimicrobial peptides (AMPs). The expression of AMPs in atopic dermatitis (AD) is still emerging. To gain more insight into the role of AMPs in AD, we systematically analyzed the expression of ribonuclease 7 (RNase 7), psoriasin, and human beta-defensins (hBD)-2 and -3 in AD compared with psoriatic and healthy control skin as well as after experimental barrier disruption. Immunostaining revealed enhanced expression of all AMPs in the lesional skin of untreated AD and psoriasis when compared with non-lesional skin and controls. Accordingly, induced in vivo secretion of RNase 7, psoriasin, and hBD-2 was detected using ELISA on lesional skin in AD and in even higher concentrations in psoriasis. The secretion of AMPs did not correlate with severity of AD and Staphylococcus aureus colonization. Skin barrier disruption caused enhanced immunoreactivity of hBD-2 and hBD-3 after 24 hours. Strong secretion of RNase 7 was already detected after 1 hour, whereas hBD-2 secretion was significantly enhanced after 24 hours only under occlusion. Thus, a disturbed skin barrier may trigger AMP induction in AD and psoriasis. The functional role of AMP in AD, especially with regard to the control of S. aureus colonization, needs further analysis.
AuthorsJürgen Harder, Stefanie Dressel, Maike Wittersheim, Jesko Cordes, Ulf Meyer-Hoffert, Ulrich Mrowietz, Regina Fölster-Holst, Ehrhard Proksch, Jens-Michael Schröder, Thomas Schwarz, Regine Gläser
JournalThe Journal of investigative dermatology (J Invest Dermatol) Vol. 130 Issue 5 Pg. 1355-64 (May 2010) ISSN: 1523-1747 [Electronic] United States
PMID20107483 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antimicrobial Cationic Peptides
  • DEFB4A protein, human
  • S100 Proteins
  • S100A7 protein, human
  • beta-Defensins
  • beta-defensin 3, human
  • Ribonucleases
  • Ribonuclease 7
Topics
  • Adolescent
  • Adult
  • Aged
  • Antimicrobial Cationic Peptides (metabolism)
  • Biopsy
  • Child
  • Child, Preschool
  • Dermatitis, Atopic (immunology, metabolism, pathology)
  • Epidermis (injuries, metabolism, pathology)
  • Female
  • Humans
  • Infant
  • Male
  • Middle Aged
  • Psoriasis (immunology, metabolism, pathology)
  • Ribonucleases (metabolism, secretion)
  • S100 Proteins (metabolism, secretion)
  • Severity of Illness Index
  • Staphylococcal Skin Infections (immunology, metabolism, pathology)
  • Young Adult
  • beta-Defensins (metabolism, secretion)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: